---
title: "Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281948400.md"
description: "Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline"
datetime: "2026-04-08T00:38:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281948400.md)
  - [en](https://longbridge.com/en/news/281948400.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281948400.md)
generator: "portal-rs"
---

# Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline

Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline

### Related Stocks

- [IMM.AU](https://longbridge.com/en/quote/IMM.AU.md)
- [IMMP.US](https://longbridge.com/en/quote/IMMP.US.md)

## Related News & Research

- [IMM: Discontinuation of TACTI-004 caused impairment, but strong cash and positive clinical data support future prospects](https://longbridge.com/en/news/297439554.md)
- [IMM: First-in-class immunotherapies efti and IMP761 advance in oncology and autoimmunity](https://longbridge.com/en/news/296543630.md)
- [APA NEAP pipeline wins Queensland Coordinated Project status for environmental review](https://longbridge.com/en/news/297708631.md)
- [Should Silicon Labs’ Grant-Backed Austin R&D Expansion Require Action From Silicon Laboratories (SLAB) Investors?](https://longbridge.com/en/news/298104738.md)
- [Total Voting Rights | SHEL Stock News](https://longbridge.com/en/news/297996096.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**